Long-term treatment of recurrent and chronic depression

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL.,24, 2001, Pages 3-5

  Keller, M B ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SERTRALINE;

ARTICLE; CHRONIC DISEASE; COMORBIDITY; DEPRESSION; DISABILITY; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE;

ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; CLINICAL TRIALS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COST OF ILLNESS; DEPRESSIVE DISORDER; DISABILITY EVALUATION; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; HUMANS; PLACEBOS; RECURRENCE; TREATMENT OUTCOME; TRIAZOLES;

EID: 0034787406     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
2. The long-term treatment of depression
3. The course of depression in adult outpatients: Results from the Medical Outcomes Study
4. Time to recovery, chronicity, and levels of psychopathology in major depression: A 5-year prospective follow-up of 431 subjects
5. Recovery after 5 years of unremitting major depressive disorder
6. Anxiety symptom relief in depression treatment outcomes
7. The difficult depressed patient in perspective
8. Depression: Underrecognition and undertreatment by psychiatrists and other health care professionals
9. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients
10. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study
11. The economic burden of depression in 1990
12. Depression and cardiac mortality: Results from a community-based longitudinal study
13. The enduring psychosocial consequences of mania and depression
14. Comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression
15. The treatment of chronic depression, part 2: A double-blind, randomized trial of sertraline and imipramine
16. The prophylactic efficacy of fluoxetine in unipolar depression
17. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
18. Sertraline in the prevention of depression
19. A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression
20. Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression
21. Mirtazapine versus amitriptyline in the long-term treatment of depression: A double-blind placebo-controlled study
22. Three-year outcomes for maintenance therapies in recurrent depression
23. Maintenance phase efficacy of sertraline for chronic depression
24. Five-year outcome for maintenance therapies in recurrent depression
25. The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression